Shelter Pharma Limited (BOM:543963)
28.13
-0.92 (-3.17%)
At close: Jul 7, 2026
Shelter Pharma Revenue
In the fiscal year ending March 31, 2026, Shelter Pharma had annual revenue of 731.34M INR with 44.36% growth. Shelter Pharma had revenue of 398.41M in the half year ending March 31, 2026, with 92.37% growth.
Revenue
731.34M
Revenue Growth
+44.36%
P/S Ratio
0.62
Revenue / Employee
n/a
Employees
69
Market Cap
456.28M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 731.34M | 224.74M | 44.36% |
| Mar 31, 2025 | 506.60M | 106.37M | 26.58% |
| Mar 31, 2024 | 400.23M | 38.70M | 10.70% |
| Mar 31, 2023 | 361.53M | 60.97M | 20.29% |
| Mar 31, 2022 | 300.56M | 75.72M | 33.68% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.42B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Walpar Nutritions | 757.46M |
| Sandu Pharmaceuticals | 699.35M |
| Biofil Chemicals and Pharmaceuticals | 314.78M |
Shelter Pharma News
- 5 weeks ago - Shelter Pharma Quarterly report: Q4 2026 - Filings
- 8 months ago - Shelter Pharma Quarterly report: Q2 2026 - Filings